- Learn the basics
- Find stocks
- Understand a stock
- Compare with peers
ASTRAZENECA PLC
AZN United States NYSEAstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Andexxa/Ondexxya, Atacand, Atacand HCT, Atacand Plus, Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, Xigduo/Xigduo, and Zestril XR for cardiovascular, renal, and metabolism diseases; Accolate, Accoleit, Vanticon, Bevespi Aerosphere, Breztri Aerosphere, Bricanyl Respules and Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Rhinocort, Saphnelo, Symbicort, and Tezspire for respiratory and immunology; and Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. Its marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and Personalis, Inc, as well as research collaboration with Sernova Corp. to evaluate novel potential therapeutic cell applications. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
The bars show each projection's high and low scenario. The more likely an outcome, the more solid its half of the bar: for the DCF, how often 400 simulations of the company's growth and margins reach that scenario; for the growth plans, up means the plans succeed and no expected decline hits, down means the plans fail and the declines hit. Switch them off with Ranges.
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company, how factual it is and the market mood it conveys (an animal label such as Bull or Bear - hover it for the meaning). What the ratings mean.
More Health Care stocks
- ArriVent BioPharma, Inc. (AVBP)
- Arrowhead Pharmaceuticals, Inc. (ARWR)
- ARS Pharmaceuticals, Inc. (SPRY)
- Artelo Biosciences, Inc. (ARTL)
- Artiva Biotherapeutics, Inc. (ARTV)
- Artivion, Inc. (AORT)
- Arvinas, Inc. (ARVN)
- Ascendis Pharma A/S (ASND)
- Ascentage Pharma Group International (AAPG)
- Aspire-Lakewood Holdings, Inc. (ASBP)
- Aspire-Lakewood Holdings, Inc. (ASBPW)
- Assembly Biosciences, Inc. (ASMB)
- ASTROTECH Corp (ASTC)
- AtaiBeckley Inc. (ATAI)
- Atara Biotherapeutics, Inc. (ATRA)
- Atea Pharmaceuticals, Inc. (AVIR)
- Atossa Therapeutics, Inc. (ATOS)
- AtriCure, Inc. (ATRC)
- Atrium Therapeutics, Inc. (RNA)
- Attovia Therapeutics, Inc. (ATTO)
- aTYR PHARMA INC (ATYR)
- Auna S.A. (AUNA)
- Aura Biosciences, Inc. (AURA)
- Aurinia Pharmaceuticals Inc. (AUPH)